Gastrointestinal-Disease Medical Cannabis Studies

• View All (505)

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (2013)

According to the results obtained using mice as a sample, the positive effect of cannabigerol (CBG), a cannabinoid derivative of non-psychotropic cannabis, in a murine model of colitis could be verified. Its use is possible for the treatment of patients with inflammatory bowel disease (IBD). Because CBG attenuated murine colitis, it reduced the production of nitric oxide in macrophages (effect modulated by the CB2 receptor) and reduced ROS formation in intestinal epithelial cells View study
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (2011)

Cannabidiol (CBD) due to its ability to control reactive gliosis in the central nervous system but without the psychotropic effects, can be a new therapeutic alternative in the treatment of inflammatory bowel diseases. View study
Cannabinoids and the gastrointestinal tract (2001)

This research focuses on the study Cannabinoids and the gastrointestinal tract. The tests conducted in this study suggest further research to investigate the role of both endogenous cannabinoid receptor agonists and non-CB1 cannabinoid receptors in the gastrointestinal tract. View study
Cannabis use amongst patients with inflammatory bowel disease (2011)

This study focused on evaluating cannabis use in patients with inflammatory bowel disease (IBD). The results showed that the use of cannabis is common among patients with IBD for the relief of symptoms, particularly among those with a history of abdominal surgery, chronic abdominal pain and / or a low quality of life index. View study
Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease (2013)

The objective of this research was to assess the prevalence, sociodemographic characteristics and perceived benefits of marijuana use in patients with inflammatory bowel disease (IBD). The results of this study indicate that a large number of patients consume marijuana. Most patients find it very useful for the control of symptoms, including patients with ulcerative colitis. More studies are needed on marijuana as an IBD therapy View study
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract (2013)

This research was based on the study of the effect in rats of a simple extract of medicinal cannabis called (MFF) for its ability to promote the resolution of colitis, prevent gastric damage induced by naproxen and decrease gastric distention induced. visceral pain. The results showed that a simple medicinal cannabis extract can significantly improve the resolution of inflammation and lesions, as well as prevent injuries, in the gastrointestinal tract. View study